Saratoga Research & Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$20M |
| 2 |
Eli Lilly
LLY
|
+$18M |
| 3 |
Starbucks
SBUX
|
+$9.97M |
| 4 |
Honeywell
HON
|
+$5.83M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$4.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$27.3M |
| 2 |
Oracle
ORCL
|
+$24.2M |
| 3 |
RTX Corp
RTX
|
+$13.8M |
| 4 |
C.H. Robinson
CHRW
|
+$13.6M |
| 5 |
Nike
NKE
|
+$9.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.46% |
| 2 | Healthcare | 19.15% |
| 3 | Communication Services | 16.12% |
| 4 | Consumer Staples | 13.03% |
| 5 | Industrials | 9.56% |
Similar funds
Saratoga Research & Investment Management's Q3 2025 Portfolio in Review
As of Q3 2025, Saratoga Research & Investment Management held 44 positions worth $1.92B, up 2.9% from $1.87B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Saratoga Research & Investment Management withdrew a net $64.7M in Q3 2025, closing 1 position and reducing 27 holdings. Its most notable exit was Cognizant, an estimated $580K position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Saratoga Research & Investment Management added an estimated $20M to Novo Nordisk.
- Saratoga Research & Investment Management added most to Novo Nordisk in Q3 2025, an estimated $20M increase.
- Saratoga Research & Investment Management's biggest Q3 2025 reduction was Walt Disney, cutting an estimated $27.3M.
- Saratoga Research & Investment Management fully exited Cognizant in Q3 2025, selling an estimated $580K.
- Saratoga Research & Investment Management's ten largest holdings make up 63% of its $1.92B portfolio in Q3 2025.
- Saratoga Research & Investment Management opened 0 new positions and closed 1 in Q3 2025.
- Saratoga Research & Investment Management's portfolio value rose 2.9% quarter-over-quarter to $1.92B.
Based on Saratoga Research & Investment Management's 13F filing for Q3 2025, filed 17 Nov 2025.